BioPharmX is a specialty pharmaceutical company focused on utilizing proprietary drug delivery technologies to develop and commercialize novel prescription, over-the-counter and supplement products that address large markets in dermatology and women’s health. The Company’s objective is to develop products that treat health or age-related conditions that are not presently being addressed or treated at all or are currently treated with drug therapies or drug delivery approaches that are sub-optimal. BioPharmX has developed a product portfolio using its drug delivery technologies, including delivery mechanisms for antibiotics, biologic materials, and molecular iodine. The Company currently has one marketed product, a VI2OLET iodine dietary supplement, two clinical‑stage product candidates, BPX01 and BPX03 and one development‑stage product candidate, BPX02. VI2OLET is a molecular iodine dietary supplement that addresses cyclic breast discomfort and is clinically demonstrated to alleviate the symptoms associated with FBC, including tenderness, aches, and swelling. BPX03 is a prescription drug version of the molecular iodine tablet for the treatment of moderate to severe, periodic breast pain associated with FBC and cyclic mastalgia. BPX01 is a hydrophilic, topical antibiotic gel for the treatment of acne vulgaris and BPX02 is an injectable product utilizing biologic materials for aesthetic dermatology applications.